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Introduction

40
While the early stages of herpesvirus assembly take place in the nucleus, the final 
54
This study concerns the functions of the HSV UL16 protein in virion assembly.
55
Orthologs of the HSV UL16 protein are conserved throughout the Herpesviridae, however its 
75
The goal of this study was to resolve this controversy by performing a side-by-side Fig. 2A) . Similarly, all HSV-1 UL16 mutants formed visible plaques on 121 complementing L16K cells, but not on L cells (Fig. 2C) . Importantly, all UL16 null strains 122 formed visible plaques on non-complementing Vero cells, albeit much smaller than those 123 formed in comparison to their parental strains ( Fig. 2A and 2C ), indicating some capacity for 124 spread between Vero cells that was not seen on L cell monolayers. These data suggested 125 that HSV-1 and HSV-2 UL16 mutants have similar deficiencies in cell-to-cell spread.
126
To quantify the abilities of UL16 deletion viruses to spread, we measured the area of (Fig. 2B ). In addition, the 132 plaque size of our original HSV-2 186 strain UL16 null mutant, D16, was 14% that of WT 186 133 strain (Fig. 2B) . Surprisingly, all HSV-1 UL16 null mutants formed plaques roughly 95% (Fig. 6) . However, fewer enveloped cytoplasmic capsids were observed in cells 174 infected with the UL16 mutant, UL16FD139-359 (Fig. 6D ), compared to HSV-1 (F) infected 175 cells (Fig. 6B) . These findings are consistent with previous reports indicating that HSV-1 UL16 176 functions in secondary envelopment (8).
177
To quantify the distribution of capsids in the presence and absence of UL16, viral 178 particles at various stages of maturation were classified and counted in ten independent 179 images of Vero cells infected with the strains listed in Table 2 and the ratios of intranuclear C-180 capsids:cytoplasmic capsids and enveloped:cytoplasmic capsids were analyzed in more 181 detail (Fig. 7) . We chose to focus on intranuclear C-capsids, instead of A, B and C-capsids (Fig. 9) . Both Vero16 and Vero16K cells were able to support the nuclear egress of 201 UL16SD10-360 as evidenced by the appearance of numerous cytoplasmic capsids (Fig.8A, 
202
B). Quantification of these data indicated that HSV-2 and HSV-1 UL16 were indistinguishable 203 in their ability to complement the UL16SD10-360 nuclear egress defect ( Figure 9A ).
204
Expression of HSV-1 UL16, but not HSV-2 UL16, modestly, but significantly, promoted the 
Discussion
211
Here we describe the analysis of UL16 deletion mutants derived from four HSV strains.
212
The strategy used to construct these strains utilized CRISPR/Cas9 mutagenesis which was 213 both efficient and rapid. Our approach utilized two gRNAs towards the UL16 locus severely than other HSV-1 UL16 mutants (Fig. 3D) . It is not clear why UL16FFS27/3 grows as 222 poorly as it does, however, it is noteworthy that it forms smaller plaques on complementing 223 cells than the other HSV-1 UL16 mutants (Fig.4B) raising the possibility that additional 224 mutations outside the UL16 locus were introduced during its isolation. Alternatively, the N-225 terminal fragment of UL16, predicted to be produced by UL16FFS27/3, might act as a 226 dominant negative protein resulting in the inhibition of both cell-to-cell spread and virus 227 replication. Clearly, more work is required to determine the cause of the UL16FFS27/3 cell-to-228 12 cell spread and replication phenotypes. Because of these caveats we eliminated this strain 229 from subsequent ultrastructural analyses.
230
Our kinetic analysis of UL16 mutant replication revealed that HSV-2 UL16 mutants had 231 roughly 50 to 100-fold reductions in virus replication while HSV-1 UL16 mutants, with the 232 exception of UL16FFS27/3 (see above), had approximately 10-fold reductions (Fig. 3) . These 233 results are consistent with previous findings suggesting HSV-2 and HSV-1 have differential 234 requirements for UL16 (6-8). Despite replicating better than HSV-2 UL16 deletion mutants 235 (Fig. 3) , HSV-1 UL16 mutants consistently formed slightly smaller plaques relative to their 236 parental strains than the HSV-2 UL16 mutants (Fig. 2) . These findings may suggest that HSV- In support of this idea, it is noteworthy that the N-terminus of UL16 is less conserved between 246 HSV-2 and HSV-1 than the remainder of the protein (16) and our preliminary investigations 247 suggest that gE glycosylation is unperturbed in cells infected with HSV-2 D16 (data not 248 shown).
249
Our trans-complementation plaque assays revealed that HSV-1 UL16 can rescue 250 plaque formation of HSV-2 UL16 mutants and vice versa (Fig. 4) . Furthermore, TEM analysis 251 13 revealed that HSV-1 UL16 can promote the nuclear egress of HSV-2, despite not being 252 required for HSV-1 nuclear egress ( Fig. 8 and 9A ). Our findings also indicate that both HSV-2 253 and HSV-1 UL16 function in secondary envelopment and that these proteins are trans-254 complementary for this process (Fig.8 and 9B (Table 2) . Taken together, these findings suggest that 266 UL16 influences multiple stages of virion morphogenesis.
267
The goal of this study was to resolve an apparent discrepancy between the functions of penicillin-streptomycin, and 1% GlutaMAX and grown at 37°C in a 5% CO 2 environment.
287
UL16 expressing cell lines were isolated by retroviral transduction using an 288 amphotropic Phoenix-Moloney murine leukemia virus system described previously (17). In Plasmid construction. pBMN-IP-UL16 encoding HSV-2 UL16 was constructed previously (6).
313
To construct pBMN-IP-UL16K, UL16 KOS sequences were amplified from HSV-1 KOS 314 genomic DNA by PCR using the forward primer 5'-GACTGAATTCATGG CGCAGCTGGGAC- (Table 1 ) and the double-stranded product was cloned into pX330-U6-Chimeric_BB-CBh- Roughly 50% of plaques picked had UL16 deletions or frame shift mutations. 
